NCT00250783

Brief Summary

The purpose of this study is to provide a repository for long-term storage of endometrial cancer tumor and normal tissue, ascites and serum. This material will be used in studies to better understand the molecular biology of endometrial cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2002

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

November 4, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 8, 2005

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

5.5 years

First QC Date

November 4, 2005

Last Update Submit

March 9, 2024

Conditions

Keywords

Corpus UteriEndometriumCancer

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

tumor and normal tissues, ascites, and/or serum, and/or urine from women with malignant or premalignant gynecological conditions for which they are undergoing medically-indicated surgery, and normal tissues from women without malignancy who volunteer to donate serum and/or tissue at the time of medically indicated surgery.

You may qualify if:

  • All patients undergoing hysterectomy, or who have endometrial cancer, and are under routine surveillance.
  • Patients may have received prior hormonal, cytotoxic chemotherapy, irradiation or surgical therapy.
  • Healthy post-menopausal and peri-menopausal women.
  • A consent form must be signed by the patient prior to study entry.

You may not qualify if:

  • Study Patients:
  • Patients who do not have primary uterine corpus tumors.
  • Patients with less than one gram of tumor tissue available to procurement.
  • Controls:
  • Patients unwilling to have their medical records reviewed for height, weight, and general medical history (see attached data sheets).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of New Mexico

Albuquerque, New Mexico, 87131, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Tumor and normal tissues, ascites, and/or serum, and/or urine from women with malignant or premalignant gynecological conditions for which they are undergoing medically-indicated surgery, and normal tissues from women without malignancy who volunteer to donate serum and/or tissue at the time of medically indicated surgery

MeSH Terms

Conditions

Endometrial NeoplasmsUterine NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Harriet Smith, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2005

First Posted

November 8, 2005

Study Start

July 1, 2002

Primary Completion

January 1, 2008

Study Completion

January 1, 2008

Last Updated

March 12, 2024

Record last verified: 2024-03

Locations